Arcadia Biosciences (RKDA) Misses Q4 EPS by 3c

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $540 thousand versus the consensus estimate of $1 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Plexus Corp (PLXS) Tops Q2 EPS by 7c
• Newmarket (NEU) Reports Q1 EPS of $11.23
• Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance